We are live on
!
Find out more
WC
Weil Company Portfolio holdings
AUM
$445M
1-Year Est. Return
14.95%
This Fund
S&P 500
This Quarter
Est. Return
-1.62%
1 Year Est. Return
+14.95%
3 Year Est. Return
+51.9%
5 Year Est. Return
+85.1%
10 Year Est. Return
–
AUM
$199M
AUM Growth
-$15.4M
(-7.2%)
Cap. Flow
-$8.2M
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
41.56%
Holding
155
New
13
Increased
40
Reduced
43
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$2.42M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$1.95M |
| 3 |
BNY Mellon Concentrated International ETF
BKCI
|
+$1.88M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.83M |
| 5 |
Rockwell Automation
ROK
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.79M |
| 2 |
Houlihan Lokey
HLI
|
+$2.17M |
| 3 |
Hain Celestial
HAIN
|
+$1.65M |
| 4 |
Fortinet
FTNT
|
+$1.25M |
| 5 |
Gilead Sciences
GILD
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.98% |
| 2 | Real Estate | 16.95% |
| 3 | Financials | 13.22% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares Gold Trust
IAU
$62.5B
| $2.11M | 1.06% |
57,306
-23,510
| -29% | -$840K |
|
27
Verisk Analytics
VRSK
$27.8B
| $2.04M | 1.02% |
9,493
+165
| +2% | +$32.5K |
|
28
Freeport-McMoran
FCX
$88.6B
| $1.97M | 0.99% |
39,612
-4,924
| -11% | -$218K |
|
29
Starbucks
SBUX
$118B
| $1.89M | 0.95% |
20,722
-305
| -1% | -$28.8K |
|
|
30
BNY Mellon Concentrated International ETF
BKCI
$133M
| $1.84M | 0.92% |
+39,750
| New | +$1.88M |
|
|
31
iShares Core US Aggregate Bond ETF
AGG
$138B
| $1.78M | 0.89% |
+16,585
| New | +$1.83M |
|
32
PTC
PTC
$14.7B
| $1.71M | 0.86% |
15,830
| – | – |
|
33
Meta Platforms (Facebook)
META
$1.51T
| $1.59M | 0.8% |
7,153
+382
| +6% | +$95.5K |
|
34
Illumina
ILMN
$29.2B
| $1.55M | 0.78% |
4,558
+279
| +7% | +$94.2K |
|
35
Amdocs
DOX
$5.83B
| $1.52M | 0.77% |
18,527
-92
| -0.5% | -$7.21K |
|
36
Alibaba
BABA
$276B
| $1.42M | 0.71% |
13,005
+8,569
| +193% | +$987K |
|
37
Groupon
GRPN
$1.07B
| $1.38M | 0.69% |
71,757
+43,459
| +154% | +$966K |
|
38
W.W. Grainger
GWW
$66B
| $1.38M | 0.69% |
2,673
-632
| -19% | -$311K |
|
39
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
| $1.37M | 0.69% |
8,665
-1,454
| -14% | -$227K |
|
40
CSX Corp
CSX
$94.2B
| $1.35M | 0.68% |
36,000
| – | – |
|
41
Gen Digital
GEN
$16.6B
| $1.29M | 0.65% |
48,731
+7,731
| +19% | +$213K |
|
42
Palo Alto Networks
PANW
$260B
| $1.25M | 0.63% |
12,090
-10,374
| -46% | -$928K |
|
|
UCTT
43
Ultra Clean Holdings
UCTT
$3.47B
| $1.24M | 0.62% |
29,305
+5,945
| +25% | +$285K |
|
44
Fluor
FLR
$6.89B
| $1.2M | 0.6% |
41,941
+2,005
| +5% | +$48.4K |
|
45
Arista Networks
ANET
$214B
| $1.16M | 0.58% |
33,368
-18,792
| -36% | -$594K |
|
46
Bank of America
BAC
$439B
| $1.13M | 0.57% |
27,482
-18,966
| -41% | -$856K |
|
|
HBI
47
DELISTED
Hanesbrands
HBI
| $1.13M | 0.57% |
76,037
+8,494
| +13% | +$134K |
|
|
BNY
48
Bank of New York Mellon
BNY
$106B
| $1.13M | 0.57% |
22,688
| – | – |
|
49
Starwood Property Trust
STWD
$6.18B
| $1.13M | 0.57% |
46,577
+5,936
| +15% | +$143K |
|
50
American Express
AXP
$227B
| $1.12M | 0.56% |
6,000
| – | – |
|
Similar funds
RWM
BI
MLIC
JDLA
AFA
SGCM
WCP
ACA
Weil Company's Q1 2022 Portfolio in Review
As of Q1 2022, Weil Company held 155 positions worth $199M, down 7.2% from $214M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Weil Company withdrew a net $8.2M in Q1 2022, closing 31 positions and reducing 43 holdings. Its most notable exit was Gilead Sciences, an estimated $1.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 30% a quarter earlier, followed by Real Estate and Financials.
Against the trend, Weil Company opened a new position in BNY Mellon Concentrated International ETF worth $1.84M.
- Weil Company's largest Q1 2022 buy was BNY Mellon Concentrated International ETF: 39,750 shares worth $1.84M.
- Weil Company added most to United Therapeutics in Q1 2022, an estimated $2.42M increase.
- Weil Company's biggest Q1 2022 reduction was Apple, cutting an estimated $2.79M.
- Weil Company fully exited Gilead Sciences in Q1 2022, selling an estimated $1.2M.
- Weil Company's ten largest holdings make up 42% of its $199M portfolio in Q1 2022.
- Weil Company opened 13 new positions and closed 31 in Q1 2022.
- Weil Company's portfolio value fell 7.2% quarter-over-quarter to $199M.
Based on Weil Company's 13F filing for Q1 2022, filed 6 May 2022.